Dare Bioscience, Inc. Paid-in-Kind Interest
Dare Bioscience, Inc. (DARE) reported Paid-in-Kind Interest of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2019-04-01
- Dare Bioscience, Inc. paid-in-kind interest for the quarter ending 2017-12-31 was $1.00.
- Dare Bioscience, Inc. paid-in-kind interest for the quarter ending 2015-09-30 was $229.00K, a 129.00% increase year-over-year.
- Dare Bioscience, Inc. paid-in-kind interest for the quarter ending 2015-06-30 was $276.00K, a 153.21% increase year-over-year.
- Dare Bioscience, Inc. paid-in-kind interest for the quarter ending 2015-03-31 was $515.00K, a 329.17% increase year-over-year.
- Dare Bioscience, Inc. paid-in-kind interest for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Dare Bioscience, Inc. paid-in-kind interest for fiscal 2017 was $316.81K.
- Dare Bioscience, Inc. paid-in-kind interest for fiscal 2014 was $416.00K, a 29.25% decline from fiscal 2013.
- Dare Bioscience, Inc. paid-in-kind interest for fiscal 2013 was $588.00K, a 863.93% increase from fiscal 2012.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month | Paid-in-Kind Interest 100 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-04-01 | ||||
| 2017-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $316.81K 10-K · filed 2019-04-01 | |||
| 2017-09-30 | $316.80K 10-Q · filed 2018-11-13 | ||||
| 2015-09-30 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $505.00K derived: sum of 2 quarters · filed 2015-11-16 | $1.02M 10-Q · filed 2015-11-16 | $1.11M derived: sum of 4 quarters · filed 2015-11-16 | |
| 2015-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $791.00K 10-Q · filed 2015-08-06 | $878.00K derived: sum of 3 quarters · filed 2015-08-06 | $978.00K derived: sum of 4 quarters · filed 2015-11-16 | |
| 2015-03-31 | $515.00K 10-Q · filed 2015-05-06 | $602.00K derived: sum of 2 quarters · filed 2015-05-06 | $702.00K derived: sum of 3 quarters · filed 2015-11-16 | $811.00K derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $187.00K derived: sum of 2 quarters · filed 2015-11-16 | $296.00K derived: sum of 3 quarters · filed 2015-11-16 | $416.00K 10-K · filed 2015-03-19 | |
| 2014-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $209.00K derived: sum of 2 quarters · filed 2015-11-16 | $329.00K 10-Q · filed 2015-11-16 | $460.00K derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $229.00K 10-Q · filed 2015-08-06 | $360.00K derived: sum of 3 quarters · filed 2015-08-06 | $502.00K derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | $120.00K 10-Q · filed 2015-05-06 | $251.00K derived: sum of 2 quarters · filed 2015-05-06 | $393.00K derived: sum of 3 quarters · filed 2015-05-06 | $545.00K derived: sum of 4 quarters · filed 2015-05-06 | $988.00K 10-Q · filed 2014-05-27 |
| 2013-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $273.00K derived: sum of 2 quarters · filed 2015-03-19 | $425.00K derived: sum of 3 quarters · filed 2015-03-19 | $588.00K 10-K · filed 2015-03-19 | |
| 2013-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $294.00K derived: sum of 2 quarters · filed 2014-11-13 | $457.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $315.00K 10-Q · filed 2014-08-12 | |||
| 2013-03-31 | $163.00K 10-Q · filed 2014-05-27 | ||||
| 2012-12-31 | $61.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |